(1)
Babak, O. Y.; Lapshyna, K. A. The Fibroblasts Growth Factor 21 Study in Patients With Non-Alcoholic Fatty Liver Disease and Hypertension Comorbidities. Zaporozhye Medical Journal 2020, 22.